Publicaciones en las que colabora con Angel Arenal Maíz (118)

2024

  1. Cannon A wave validation as a diagnostic tool in paroxysmal supraventricular tachycardias

    PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 3, pp. 383-391

2023

  1. Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7

  2. Complications and inappropriate shocks in pediatric patients receiving a subcutaneous implantable cardioverter defibrilator

    Revista Espanola de Cardiologia

2022

  1. Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias

    Heart (British Cardiac Society), Vol. 108, Núm. 14, pp. 1107-1113

  2. Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic

    BioTech, Vol. 11, Núm. 3

  3. Combined atrial fibrillation ablation and balloon mitral commissurotomy in patients with rheumatic mitral stenosis

    Journal of Cardiovascular Electrophysiology, Vol. 33, Núm. 12, pp. 2485-2495

  4. Convolutional Neural Networks for Mechanistic Driver Detection in Atrial Fibrillation

    International Journal of Molecular Sciences, Vol. 23, Núm. 8

  5. Effects of Cardiac Stem Cell on Postinfarction Arrhythmogenic Substrate

    International Journal of Molecular Sciences, Vol. 23, Núm. 24

  6. Intrapericardial cardiosphere-derived cells hinder epicardial dense scar expansion and promote electrical homogeneity in a porcine post-infarction model

    Frontiers in Physiology, Vol. 13

  7. Structural Remodeling and Rotational Activity in Persistent/Long-Lasting Atrial Fibrillation: Gender-Effect Differences and Impact on Post-ablation Outcome

    Frontiers in Cardiovascular Medicine, Vol. 9

  8. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

    Journal of the American College of Cardiology, Vol. 79, Núm. 15, pp. 1441-1453

2021

  1. Artificial Intelligence-Driven Algorithm for Drug Effect Prediction on Atrial Fibrillation: An in silico Population of Models Approach

    Frontiers in Physiology, Vol. 12

  2. Personalized evaluation of atrial complexity of patients undergoing atrial fibrillation ablation: A clinical computational study

    Biology, Vol. 10, Núm. 9

2020

  1. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: Quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry

    Europace, Vol. 22, Núm. 6, pp. 888-896

  2. Permanent atrioventricular block after flecainide testing

    Revista Espanola de Cardiologia, Vol. 73, Núm. 2, pp. 177-178

  3. Predictors of pacemaker dependency in patients implanted with a pacemaker after Transaortic valve replacement

    IJC Heart and Vasculature, Vol. 31

  4. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy

    ESC Heart Failure, Vol. 7, Núm. 1, pp. 279-283

  5. Radiofrequency treatment for electrical storm: evolution and monitoring

    Archivos de cardiologia de Mexico, Vol. 90, Núm. 4, pp. 379-388

  6. Real-Time Ventricular Cancellation in Unipolar Atrial Fibrillation Electrograms

    Frontiers in Bioengineering and Biotechnology, Vol. 8

2019

  1. Epicardial ablation for ventricular tachycardia in Freidreich's ataxia cardiomyopathy

    Europace